The novel prognostic SLEscore with five key therapeutic targets (RACGAP1, HMMR, TTK, TOP2A, and KIF15) was developed for the management of breast cancer patients with SLE using the LASSO algorithm. This evidence concerns the gene TTK and systemic lupus erythematosus.